Volume | 4 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Hologic Inc | HOLX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
74.92 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
4 | 4 | - | 64.02 - 87.88 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
07:27:40 | 1 | $ 74.54 | USD |
Hologic Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
17.59B | 234.73M | - | 4.05B | 456M | 1.94 | 38.57 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Hologic News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HOLX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 78.18 | 78.35 | 74.70 | 76.48 | 1,623,506 | -3.26 | -4.17% |
1 Month | 75.04 | 79.22 | 74.70 | 76.82 | 1,567,752 | -0.12 | -0.16% |
3 Months | 74.50 | 79.22 | 71.25 | 75.21 | 1,813,231 | 0.42 | 0.56% |
6 Months | 68.99 | 79.22 | 64.02 | 72.58 | 1,847,418 | 5.93 | 8.60% |
1 Year | 83.65 | 87.88 | 64.02 | 74.75 | 1,745,152 | -8.73 | -10.44% |
3 Years | 76.38 | 87.88 | 59.78 | 73.11 | 1,757,000 | -1.46 | -1.91% |
5 Years | 43.55 | 87.88 | 26.49 | 65.48 | 1,898,602 | 31.37 | 72.03% |
Hologic Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |